SER · Categories · Form 4

SER - SEC Form 4 insider transactions

Serina Therapeutics Inc. (SER) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.

Recent Form 4 for SER

• 5d
  SEC Form 4 filed by Bailey Gregory

  4 - Serina Therapeutics, Inc. (0001708599) (Issuer)
• 5d
  SEC Form 4 filed by Venkatesan Jay

  4 - Serina Therapeutics, Inc. (0001708599) (Issuer)
• 33d
  SEC Form 4 filed by Moreadith Randall

  4 - Serina Therapeutics, Inc. (0001708599) (Issuer)
• 37d
  SEC Form 4 filed by Moreadith Randall

  4 - Serina Therapeutics, Inc. (0001708599) (Issuer)
• 68d
  SEC Form 4 filed by Chief Scientific Officer Moreadith Randall

  4 - Serina Therapeutics, Inc. (0001708599) (Issuer)
• 68d
  SEC Form 4 filed by SVP, CMC & Formulation Tenjarla Srini

  4 - Serina Therapeutics, Inc. (0001708599) (Issuer)
• 68d
  SEC Form 4 filed by Director Gill Simba

  4 - Serina Therapeutics, Inc. (0001708599) (Issuer)
• 68d
  SEC Form 4 filed by Chief Executive Officer Ledger Steven A

  4 - Serina Therapeutics, Inc. (0001708599) (Issuer)
• 82d
  Chief Scientific Officer Moreadith Randall exercised 6,500 shares at a strike of $0.06 and sold $19,680 worth of shares (6,500 units at $3.03) (SEC Form 4)

  4 - Serina Therapeutics, Inc. (0001708599) (Issuer)
• 87d
  Chief Scientific Officer Moreadith Randall exercised 6,500 shares at a strike of $0.06 and sold $23,186 worth of shares (6,500 units at $3.57) (SEC Form 4)

  4 - Serina Therapeutics, Inc. (0001708599) (Issuer)
• 93d
  Chief Scientific Officer Moreadith Randall exercised 2,500 shares at a strike of $0.06 and sold $7,375 worth of shares (2,500 units at $2.95) (SEC Form 4)

  4 - Serina Therapeutics, Inc. (0001708599) (Issuer)
• 95d
  Chief Scientific Officer Moreadith Randall exercised 4,000 shares at a strike of $0.06 and sold $12,140 worth of shares (4,000 units at $3.04) (SEC Form 4)

  4 - Serina Therapeutics, Inc. (0001708599) (Issuer)
• 102d
  Chief Scientific Officer Moreadith Randall exercised 6,500 shares at a strike of $0.06 and sold $16,253 worth of shares (6,500 units at $2.50) (SEC Form 4)

  4 - Serina Therapeutics, Inc. (0001708599) (Issuer)
• 107d
  Chief Scientific Officer Moreadith Randall exercised 13,000 shares at a strike of $0.06 and sold $34,953 worth of shares (13,000 units at $2.69) (SEC Form 4)

  4 - Serina Therapeutics, Inc. (0001708599) (Issuer)
• 118d
  Chief Scientific Officer Moreadith Randall exercised 4,100 shares at a strike of $0.06 and sold $10,660 worth of shares (4,100 units at $2.60) (SEC Form 4)

  4 - Serina Therapeutics, Inc. (0001708599) (Issuer)
• 124d
  Chief Scientific Officer Moreadith Randall exercised 5,673 shares at a strike of $0.06 and sold $15,168 worth of shares (5,673 units at $2.67) (SEC Form 4)

  4 - Serina Therapeutics, Inc. (0001708599) (Issuer)
• 130d
  Chief Scientific Officer Moreadith Randall exercised 3,227 shares at a strike of $0.06 and sold $9,562 worth of shares (3,227 units at $2.96) (SEC Form 4)

  4 - Serina Therapeutics, Inc. (0001708599) (Issuer)
• 131d
  Chief Scientific Officer Moreadith Randall exercised 1,700 shares at a strike of $0.06 and sold $5,541 worth of shares (1,700 units at $3.26) (SEC Form 4)

  4 - Serina Therapeutics, Inc. (0001708599) (Issuer)
• 135d
  Chief Scientific Officer Moreadith Randall exercised 3,555 shares at a strike of $0.06 and sold $11,520 worth of shares (3,555 units at $3.24) (SEC Form 4)

  4 - Serina Therapeutics, Inc. (0001708599) (Issuer)
• 136d
  Chief Scientific Officer Moreadith Randall exercised 600 shares at a strike of $0.06, sold $4,149 worth of shares (1,245 units at $3.33) and was granted 645 shares (SEC Form 4)

  4 - Serina Therapeutics, Inc. (0001708599) (Issuer)
• 143d
  Chief Scientific Officer Moreadith Randall exercised 6,500 shares at a strike of $0.06 and sold $23,481 worth of shares (6,500 units at $3.61) (SEC Form 4)

  4 - Serina Therapeutics, Inc. (0001708599) (Issuer)
• 151d
  Chief Scientific Officer Moreadith Randall exercised 5,965 shares at a strike of $0.06 and sold $23,264 worth of shares (5,965 units at $3.90) (SEC Form 4)

  4 - Serina Therapeutics, Inc. (0001708599) (Issuer)
• 152d
  Chief Scientific Officer Moreadith Randall sold $2,105 worth of shares (535 units at $3.93) and exercised 535 shares at a strike of $0.06 (SEC Form 4)

  4 - Serina Therapeutics, Inc. (0001708599) (Issuer)
• 158d
  Chief Scientific Officer Moreadith Randall exercised 6,500 shares at a strike of $0.06 and sold $24,402 worth of shares (6,500 units at $3.75) (SEC Form 4)

  4 - Serina Therapeutics, Inc. (0001708599) (Issuer)
• 165d
  Chief Scientific Officer Moreadith Randall sold $26,650 worth of shares (6,500 units at $4.10) and exercised 6,500 shares at a strike of $0.06 (SEC Form 4)

  4 - Serina Therapeutics, Inc. (0001708599) (Issuer)
• 167d
  SEC Form 4 filed by Director Brannan Stephen K.

  4 - Serina Therapeutics, Inc. (0001708599) (Issuer)
• 167d
  SEC Form 4 filed by Director Bailey Gregory

  4 - Serina Therapeutics, Inc. (0001708599) (Issuer)
• 167d
  SEC Form 4 filed by Director Marshall Richard Peter

  4 - Serina Therapeutics, Inc. (0001708599) (Issuer)
• 167d
  SEC Form 4 filed by Director Venkatesan Jay

  4 - Serina Therapeutics, Inc. (0001708599) (Issuer)
• 167d
  SEC Form 4 filed by Director Wilson Karen J

  4 - Serina Therapeutics, Inc. (0001708599) (Issuer)
• 171d
  Chief Scientific Officer Moreadith Randall exercised 3,398 shares at a strike of $0.06 and sold $14,408 worth of shares (3,398 units at $4.24) (SEC Form 4)

  4 - Serina Therapeutics, Inc. (0001708599) (Issuer)
• 172d
  Chief Scientific Officer Moreadith Randall exercised 3,102 shares at a strike of $0.06 and sold $13,634 worth of shares (3,102 units at $4.40) (SEC Form 4)

  4 - Serina Therapeutics, Inc. (0001708599) (Issuer)
• 179d
  Chief Scientific Officer Moreadith Randall exercised 5,551 shares at a strike of $0.06 and sold $27,541 worth of shares (5,551 units at $4.96) (SEC Form 4)

  4 - Serina Therapeutics, Inc. (0001708599) (Issuer)
• 180d
  Chief Scientific Officer Moreadith Randall exercised 949 shares at a strike of $0.06 and sold $4,921 worth of shares (949 units at $5.19) (SEC Form 4)

  4 - Serina Therapeutics, Inc. (0001708599) (Issuer)
• 187d
  Chief Scientific Officer Moreadith Randall exercised 6,500 shares at a strike of $0.06 and sold $32,287 worth of shares (6,500 units at $4.97) (SEC Form 4)

  4 - Serina Therapeutics, Inc. (0001708599) (Issuer)
• 194d
  Chief Scientific Officer Moreadith Randall exercised 4,326 shares at a strike of $0.06 and sold $22,495 worth of shares (4,326 units at $5.20) (SEC Form 4)

  4 - Serina Therapeutics, Inc. (0001708599) (Issuer)
• 242d
  Chief Scientific Officer Moreadith Randall exercised 47,674 shares at a strike of $0.06 and sold $331,418 worth of shares (47,674 units at $6.95) (SEC Form 4)

  4 - Serina Therapeutics, Inc. (0001708599) (Issuer)
• 249d
  Chief Scientific Officer Moreadith Randall exercised 4,304 shares at a strike of $0.06 and sold $22,284 worth of shares (4,304 units at $5.18) (SEC Form 4)

  4 - Serina Therapeutics, Inc. (0001708599) (Issuer)
• 255d
  Chief Scientific Officer Moreadith Randall exercised 5,500 shares at a strike of $0.06 and sold $28,875 worth of shares (5,500 units at $5.25) (SEC Form 4)

  4 - Serina Therapeutics, Inc. (0001708599) (Issuer)
• 263d
  Chief Scientific Officer Moreadith Randall exercised 5,500 shares at a strike of $0.06 and sold $28,435 worth of shares (5,500 units at $5.17) (SEC Form 4)

  4 - Serina Therapeutics, Inc. (0001708599) (Issuer)
• 270d
  Chief Scientific Officer Moreadith Randall exercised 4,196 shares at a strike of $0.06 and sold $27,274 worth of shares (4,196 units at $6.50) (SEC Form 4)

  4 - Serina Therapeutics, Inc. (0001708599) (Issuer)
• 271d
  Chief Scientific Officer Moreadith Randall exercised 6,500 shares at a strike of $0.06 and sold $38,285 worth of shares (6,500 units at $5.89) (SEC Form 4)

  4 - Serina Therapeutics, Inc. (0001708599) (Issuer)
• 278d
  Chief Scientific Officer Moreadith Randall exercised 6,500 shares at a strike of $0.06 and sold $34,710 worth of shares (6,500 units at $5.34) (SEC Form 4)

  4 - Serina Therapeutics, Inc. (0001708599) (Issuer)
• 283d
  Chief Scientific Officer Moreadith Randall exercised 6,500 shares at a strike of $0.06 and sold $32,565 worth of shares (6,500 units at $5.01) (SEC Form 4)

  4 - Serina Therapeutics, Inc. (0001708599) (Issuer)
• 291d
  Chief Scientific Officer Moreadith Randall sold $36,855 worth of shares (6,500 units at $5.67) and exercised 6,500 shares at a strike of $0.06 (SEC Form 4)

  4 - Serina Therapeutics, Inc. (0001708599) (Issuer)
• 298d
  Chief Scientific Officer Moreadith Randall exercised 6,500 shares at a strike of $0.06 and sold $37,570 worth of shares (6,500 units at $5.78) (SEC Form 4)

  4 - Serina Therapeutics, Inc. (0001708599) (Issuer)
• 313d
  SEC Form 4 filed by Director Brannan Stephen K.

  4 - Serina Therapeutics, Inc. (0001708599) (Issuer)
• 381d
  SEC Form 4 filed by Director Venkatesan Jay

  4 - Serina Therapeutics, Inc. (0001708599) (Issuer)
• 381d
  SEC Form 4 filed by Director Bailey Gregory

  4 - Serina Therapeutics, Inc. (0001708599) (Issuer)
• 390d
  Chief Executive Officer Ledger Steven A acquired 95,730 shares (SEC Form 4)

  4 - Serina Therapeutics, Inc. (0001708599) (Issuer)
• 437d
  SEC Form 4 filed by Director Venkatesan Jay

  4 - Serina Therapeutics, Inc. (0001708599) (Issuer)
• 447d
  Large owner Juvenescence Ltd exercised 377,865 shares at a strike of $13.20 and was granted 1,000,000 shares (SEC Form 4)

  4 - Serina Therapeutics, Inc. (0001708599) (Issuer)
• 466d
  SEC Form 4 filed by Director Wilson Karen J

  4 - Serina Therapeutics, Inc. (0001708599) (Issuer)
• 592d
  SEC Form 4 filed by Chief Executive Officer Ledger Steven A

  4 - Serina Therapeutics, Inc. (0001708599) (Issuer)
• 614d
  SEC Form 4 filed by Chief Financial Officer Curhan Gregory S

  4 - Serina Therapeutics, Inc. (0001708599) (Issuer)
• 648d
  SEC Form 4 filed by SVP, CMC & Formulation Tenjarla Srini

  4 - Serina Therapeutics, Inc. (0001708599) (Issuer)

Other SER categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends